1. rlmcdonough
2. animegamer7947
3. m4collector
4. kenenthedmonds
5. celeste2096
1.m4collector 06/21/2018
BeyondSpring Provides Operational Updates and First-Quarter 2018 Financial Results
2.animegamer7947 02/07/2018
Summarizes Key Messages
3.lostcause47999 01/26/2018
Presents 'promising' data for lead asset Plinabulin
4.animegamer7947 01/26/2018
what happened today!!!!!
5.celeste2096 04/03/2018
Maxim Group reiterates Buy rating, $52 PT
6.kenenthedmonds 01/18/2018
Let's top the bleeding here
7.kenenthedmonds 04/25/2018
Files for 5 mln ordinary share offering
8.rlmcdonough 04/03/2018
BeyondSpring Provides Operational Update and Fourth-Quarter and Full-Year 2017 Financial Results
9.lostcause47999 01/18/2018
Attention: - BeyondSpring to Present Data from Phase 2 Portion of Study 105 Phase 2/3 Trial with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia at 2018 ASCO-SITC Clinical
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW